We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Well-Child Services for the Child Who Is Never 'Well': Implications for Clinical Practice-Reply

Michele Raddish, MD; Donald A. Goldmann, MD; Lawrence C. Kaplan, MD; James M. Perrin, MD
Arch Pediatr Adolesc Med. 1994;148(9):990-991. doi:10.1001/archpedi.1994.02170090103020.
Text Size: A A A
Published online


We thank Dr Rappo for his comments and appreciate the opportunity to respond.

The use of pertussis vaccine in children with neurologic problems has been hotly debated since the vaccine was introduced. In 1949, Dr Toomey1 evaluated the risk of neurotoxic reaction to pertussis vaccine and recommended that children with a family or personal history of seizures or any central nervous system problem not receive the pertussis vaccine. In 1953, Dr Melin2 suggested that Dr Toomey's seizure restrictions were too severe and that the risk of pertussis outweighed the risk of the vaccine in children with a seizure disorder. There are few additional data beyond these anecdotal reports about the risk of pertussis vaccine in neurologically impaired children, although we know the risk of pertussis vaccine is very low in healthy children.3 The introduction of new acellular vaccine products may further lower the risk.

Dr Rappo describes


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.